Search PubMed⌕ Search

Biomedical subjects

M Roggendorf

Publications and source records attributed to M Roggendorf.

At least 163 records · Page 9Linked to original sources

Parvovirus B19 infection in pregnancy.

Parvovirus B19 infection in pregnancy can cause hydrops fetalis resulting in fetal loss. Acute B19 infection was serologically confirmed in 80 pregnant women by ELISA. Of 80 pregnancies, 4 were terminated. Of the remaining 76 pregnancies, no fetal complications were observed in 36 (47.4%), hydrops fetalis occurred in 18 (23.7%) and no further information was available in 22 (28.9%). 15 of 18 (83.3%) fetuses with hydrops died. Intrauterine transfusion was performed in the remaining three fetuses and pregnancy continued without further complications. B19 infected fetal erythroblasts can be detected by standard histological staining methods and in situ hybridisation using a digoxigenin-labelled B19 DNA probe. Non-immune pregnant females working in kindergartens or schools should be suspended during an epidemic outbreak of B19 in such institutions.

Enzyme-Linked Immunosorbent Assay↗

Successful intrauterine treatment of fetal hydrops caused by parvovirus B19 infection.

The infection with parvovirus B19 during pregnancy causes in 1/3 of the cases an aplastic crisis in the fetus and consecutively generalized fetal hydrops as a result of severe anemia. Some cases of fetal hydrops and intrauterine death are reported. In our two cases, the fetal therapy by intrauterine intravasal transfusion was successful and the children developed normal. The techniques and indications for fetal blood sampling and the method of intrauterine intravasal transfusion are explained.

Adult↗

[Parvovirus infections in dermatology].

Human parvovirus B19 is the causative agent of erythema infectiosum and other atypical (rubelliform) exanthemas. On account of the relatively high prevalence of B19, these infections are rather frequent. They usually occur during childhood, but also up to the age of 30, and there are various clinical manifestations. During pregnancy, B19 infection may cause hydrops of the fetus with ensuing fetal death. Anti-B19 IgM and IgG can be detected by means of ELISA or RIA; B19-DNA is identified by hybridization of nucleic acid.

Humans↗

Characterization of woodchuck hepatitis virus DNA and RNA in the hepatocellular carcinomas of woodchucks.

Integration and transcription of woodchuck hepatitis virus DNA were studied by Southern and Northern blot analysis in 26 hepatocellular carcinomas and in adjacent nontumor tissue of woodchucks (Marmota monax). All liver tissue chronically infected with woodchuck hepatitis virus contained various amounts of episomal and replicative forms of woodchuck hepatitis virus DNA: episomal and replicative forms of woodchuck hepatitis virus DNA without integration were found in six tumors, episomal and integrated woodchuck hepatitis virus DNA was observed in 18 tumors and exclusively integrated woodchuck hepatitis virus DNA was found in two tumors. In most tumors and in all of the liver tissues chronically infected with woodchuck hepatitis virus, two major woodchuck hepatitis virus RNA species (3.7 and 2.1 kilobases) were detected. In tumors of two other animals (HW76 and HW89) with integrated woodchuck hepatitis virus DNA, only single major transcripts of 3.5 and 2.5 kilobases, respectively, were detected. Hybridization with subcloned woodchuck hepatitis virus DNA probes showed that both aberrant transcripts lacked the C gene and a part of the pre-S1 gene; characterization of corresponding integrated woodchuck hepatitis virus DNA sequences revealed that the C gene was deleted in one tumor, although not in the other. In agreement with the nucleic acid data, we found expression of core protein by Western blotting only in chronically infected liver tissue of these animals, but not in the corresponding tumors. Deletion of the C gene in mRNA may be due to deletion of this gene in the integrated sequences or due to transcriptional regulation.

Animals↗

Prevalence of antibodies to hepatitis C virus (HCV) in haemophiliacs.

The prevalence of 1) hepatitis C virus (HCV), an agent likely to be responsible for parenterally transmitted hepatitis non-A, non-B, 2) hepatitis B virus (HBV) and 3) human immunodeficiency virus (HIV) infection was studied in 211 patients with clotting disorders (78% of the patients had residual factor activities of less than or equal to 2%). Of these patients 71% were positive for HBV markers and 44% for HIV markers. Using a new ELISA technique, 80% were anti-HCV-positive. The prevalence of anti-HCV was greater in patients with more severe clotting disorders and was related to the total amount of replacement therapy received; the prevalence was less in older patients. Seroconversion after a single exposure to dry heat-treated factor concentrates was documented in 3 patients 3-4 months after exposure.

Factor VIII↗

Inhibition of hepatitis delta virus RNA replication in primary woodchuck hepatocytes.

Cell cultures of primary woodchuck hepatocytes can be infected with hepatitis delta virus (HDV) as demonstrated by the appearance of genomic HDV RNA 7 days after inoculation. This tissue culture system was used to study the effect of antiviral substances. Ribavirin inhibited HDV replication at a concentration of 10 micrograms/ml, if added up to three days post infection. Suramin had an inhibitory effect only when added simultaneously with the virus, at a concentration of 200 micrograms/ml. This concentration had no toxic effect on primary woodchuck hepatocytes. alpha-Amanitin showed a weak inhibitory effect only at the highest nontoxic concentration of 0.1 microgram/ml. Acyclovir had no effect.

Amanitins↗

Nosocomial and endemic infections with a genome type of adenovirus type 5.

A unique genome type of adenovirus 5 was isolated from 37 specimens of 25 patients. DNA restriction analysis was performed with seven endonucleases. Part of the patients were treated at a bone marrow transplantation unit in Munich. Nosocomial spread, rather than activation of endogenous adenovirus infection, was likely for many of them. In addition, sporadic cases suggested an endemicity of this genome type in Bavaria.

Adenoviridae Infections↗

Seroprevalence of human parvovirus B19 infection in Sao Tomé and Principe, Malawi and Mascarene Islands.

The prevalence of antibodies to human parvovirus B19 (anti-B19 IgG) in sera (n = 577) from Sao Tomé and Principe, Malawi and Mascarene Islands (Mauritius and Rodriguez Islands) was determined by antibody capture ELISA. The B19 prevalence was 51.5% on Sao Tomé and Principe, 58.4% in Malawi, and 55.0% on the Mauritius mainland and 2.2% on Rodriguez Island, indicating that B19 virus is highly prevalent not only in Europe, Japan and the Americas but also in the African region. Rodriguez Islands has a very low B19 prevalence.

Adolescent↗

Protection of woodchucks from infection with woodchuck hepatitis virus by immunization with recombinant core protein.

Woodchucks were immunized with recombinant woodchuck hepatitis virus (WHV) core antigen (WHcAg) to investigate whether such immunization protects against WHV infection. The C gene was cloned into a pUC12 vector and expressed in Escherichia coli. Core particles purified by sucrose and CsCl gradient centrifugation had a buoyant density of 1.37 g/ml which corresponded to the density of WHcAg particles present in chronically infected liver. Two animals immunized with the recombinant antigen developed high antibody titres and were protected against infection after challenge with WHV. The surface antigen (WHsAg) and WHV DNA were not detected in the sera of immunized animals after challenge and these animals did not develop anti-WHs. Three control animals developed a typical WHV infection. The protection from WHV infection may depend not on the presence of antibodies against the core protein but on a cellular immune response to WHcAg.

Animals↗

Human parvovirus B19: ELISA and immunoblot assays.

An ELISA for the detection of specific IgM and IgG against human parvovirus B19 (anti-B19 IgM and IgG) and B19 antigen is described. With ELISA anti-B19 IgM could be detected for up to 20 weeks after viraemia. Four to five months after B19 infection anti-B19 IgG titres range between 10(-6) and 10(-7). Nonspecific reactions with rheumatoid factor or IgM against rubella were not found. The ELISA for B19 antigen was shown to be as sensitive as DNA hybridisation. With immunoblotting two viral proteins of 83 kd (VP1) and 58 kd (VP2) were demonstrated. After acute infection antibodies to VP2 appear before antibodies to VP1. Immunoblotting might be used in pregnancy to determine the time of maternal infection. In a survey of a B19 outbreak in a school for medical technology, 6 (28.6%) of 21 non-immune females seroconverted.

Antibodies, Viral↗

Detection of Chlamydia trachomatis by isolation in cell culture and enzyme amplified immunoassay.

188 (139 female; 49 male) genital swabs from patients with urogenital complaints (greater than 6 weeks), 69 (33 female; 36 male) conjunctival swabs from patients with chronic conjunctivitis and 14 swabs from newborns with acute conjunctivitis were tested for the presence of Chlamydia trachomatis (Ct) by inoculation in cell culture and visualisation by indirect immunofluorescence (IFT) with a monoclonal antibody and enzyme immunoassay (ELISA). Of the 271 specimens 20 (7.4%) were Ct positive by cell culture (IFT) and 18 (6.6%) were positive by ELISA. In 184 (97.9%) urogenital specimens results between cell culture (IFT) and ELISA agreed. With ELISA 4 further genital specimens were found to be Ct positive. In 59 (85.5%) conjunctival swabs of patients with chronic conjunctivitis results between cell culture (IFT) and ELISA agreed. By inoculation of cell culture (IFT) 6 (8.7%) more Ct positive specimens could be identified which were negative in ELISA. There was complete agreement between positive and negative Ct detection with cell culture (IFT) and ELISA in the cases of acute conjunctivitis.

Acute Disease↗